M, C., C, G., AC, v. B., J, Z., A, M., K, V., . . . S, M. (2025). Preclinical in vitro and in vivo evidence for targeting CD74 as an effective treatment strategy for cutaneous T-cell lymphomas. The British journal of dermatology, 192(5), 883. https://doi.org/10.1093/bjd/ljaf001
Chicago Style (17th ed.) CitationM, Costanza, et al. "Preclinical in Vitro and in Vivo Evidence for Targeting CD74 as an Effective Treatment Strategy for Cutaneous T-cell Lymphomas." The British Journal of Dermatology 192, no. 5 (2025): 883. https://doi.org/10.1093/bjd/ljaf001.
MLA (9th ed.) CitationM, Costanza, et al. "Preclinical in Vitro and in Vivo Evidence for Targeting CD74 as an Effective Treatment Strategy for Cutaneous T-cell Lymphomas." The British Journal of Dermatology, vol. 192, no. 5, 2025, p. 883, https://doi.org/10.1093/bjd/ljaf001.